Neurodegenerative Diseases: Current Research

Call for Papers

Neurodegenerative Diseases: Current Research

ISSN (Online): 2832-9422
Volume 5, Issue 1 (2026)
📧 E-mail: editor@neurodegenerativejournal.com

Neurodegenerative Diseases: Current Research invites researchers, clinicians, neuroscientists, and healthcare professionals to submit original manuscripts for Volume 5, Issue 1 (2026).

The journal is dedicated to publishing high-quality research that advances understanding of the mechanisms, diagnosis, prevention, and treatment of neurodegenerative disorders. We aim to provide an international platform for scientific exchange and innovation in neuroscience and related disciplines.

Aim and Scope

The journal welcomes submissions in areas including, but not limited to:

• Pathophysiology of neurodegenerative diseases
• Molecular and cellular mechanisms of neurodegeneration
• Biomarkers and early diagnosis
• Genetics and epigenetics of neurological disorders
• Neuroinflammation and immune mechanisms
• Protein misfolding and aggregation
• Alzheimer’s disease and related dementias
• Parkinson’s disease and movement disorders
• Huntington’s disease
• Amyotrophic lateral sclerosis (ALS)
• Multiple sclerosis
• Neuroprotective strategies and therapeutics
• Clinical trials and translational research
• Neuroimaging and diagnostic technologies
• Computational neuroscience and disease modeling

Types of Articles Accepted

• Original Research Articles
• Review Articles
• Systematic Reviews & Meta-Analyses
• Short Communications
• Case Reports
• Clinical Studies
• Perspectives and Commentaries
• Letters to the Editor

Peer Review Process

All submissions undergo a rigorous double-blind peer-review process:

• Initial editorial screening
• Expert peer review
• Decision typically within 2–4 weeks after review
• Rapid processing of revised manuscripts

Important Dates – Volume 5 (1), 2026

• Manuscript Submission Deadline: 30 August 2026
• Notification of Acceptance: Within 2–4 weeks after peer review
• Publication Date: September 2026

Early submissions are encouraged. Accepted articles may be published online ahead of issue compilation.

Author Guidelines

Authors should ensure that:

• Submissions are original and not under consideration elsewhere
• Ethical approval and patient consent (where applicable) are clearly stated
• Conflicts of interest are disclosed
• References are formatted according to journal guidelines

Detailed author instructions are available upon request.

Editorial Board

The journal is supported by an international Editorial Board composed of experienced researchers and clinicians in neuroscience and neurodegenerative disease research. The board ensures scientific rigor, transparency, and high editorial standards.

Submission Information

Manuscripts should be submitted electronically to:

📧 editor@neurodegenerativejournal.com

For inquiries regarding submissions, special issues, or editorial policies, please contact the editorial office.

We look forward to receiving your valuable contributions and to advancing global research in neurodegenerative diseases.

Editorial Office
Neurodegenerative Diseases: Current Research
ISSN (Online): 2832-9422
Volume 5, Issue 1 (2026)
Email: editor@neurodegenerativejournal.com